Testing effectiveness (Phase 2)Study completedNCT02519322What this trial is testingNeoadjuvant and Adjuvant Checkpoint BlockadeWho this might be right forCutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more M.D. Anderson Cancer Center 53